SLC13A2-transported citrate is a metabolic signal for PKM2 acetylation and degradation to suppress tumor growth
Mengyao QiniD, Li ShiiD, Hao CheniD, Chan Liu, Zhiquan Tang, Donghao An, Wanting Yu, Dandan HeiD, Chang ShaoiD, Hong YuiD, Hong Yu, Haiping HaoiD, Jing XiongiD
Abstract
Background and aimsMetabolic reprogramming represents as a pivotal hallmark for cancer, but TCA cycle in tumorigenesis and progression has long been neglected. Solute carrier (SLC) transporters mediate the transport of TCA cycle intermediates across membrane, but their functions in cancer pathogenesis remains unclear. Approaches & ResultsUsing integrated analysis of solute carrier (SLC) transporters for TCA cycle intermediates, we found that SLC13A2 was consistently downregulated in hepatocellular carcinoma (HCC) cells and liver tissues from human patients and heterogeneous mouse models. Adeno-associated virus (AAV)-transduced liver-specific knockout or overexpression of SLC13A2 promoted or ameliorated HCC progression in the primary mouse model, demonstrating that SLC13A2 served as a protective factor during HCC pathogenesis. SLC13A2 inhibited HCC cell proliferation by decreasing mitochondrial function via suppressed oxygen consumption and ATP production. Combined with metabolic flux analysis, we found that SLC13A2 imported citrate, which secreted acetyl-CoA as a precursor for the acetylation of pyruvate kinase muscle isozyme M2 (PKM2), which led to its protein degradation. Decreased activity of pyruvate kinase depleted pyruvate for the TCA cycle, thus inhibiting amino acid synthesis and nucleotide metabolism. Additionally, a decrease in nuclear PKM2 protein transduced to reprogrammed gene transcription for cell proliferation and metabolism which is required for tumor growth. ConclusionsThis study revealed that citrate transported by SLC13A2 acts as a signal to disrupt metabolic homeostasis for tumor growth and suggests potential drug targets for HCC therapy. graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=165 SRC="FIGDIR/small/591017v2_ufig1.gif" ALT="Figure 1"> View larger version (64K): org.highwire.dtl.DTLVardef@80c95eorg.highwire.dtl.DTLVardef@124750corg.highwire.dtl.DTLVardef@809ab4org.highwire.dtl.DTLVardef@12cbe74_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 6.48
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The SLC1A1/EAAT3 Dicarboxylic Amino Acid Transporter is an Epigenetically Dysregulated Nutrient Carrier that Sustains Oncogenic Metabolic Programs
T. M. Grubb, J. Khatun, … A. A. Chakraborty·bioRxiv·Sep 4, 2023
- NaCT (SLC13A5) facilitates citrate import and metabolism under nutrient-limited conditions
A. Kumar, T. Cordes, … C. M. Metallo·bioRxiv·Apr 8, 2021
- Methionine metabolism and the NOP2 methyltransferase are essential for MYC-Driven liver tumorigenesis.
Sensen Lin, Charles A. Berdan, … Andrei Goga·bioRxiv·Jan 30, 2026
- TP promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
- The hexokinase ''HKDC1'' interaction with the mitochondria is essential for hepatocellular carcinoma progression
M. W. Khan, A. Terry, … B. T. Layden·bioRxiv·Nov 10, 2021
- PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle
M. Benzarti, A. Oudin, … J. Meiser·bioRxiv·Jan 23, 2023